Zhongtian Qi

Title: Innovations of Zhongtian Qi in Genetic Engineering

Introduction

Zhongtian Qi is a notable inventor based in Shanghai, China. He has made significant contributions to the field of genetic engineering, particularly in the production of non-erythroid proteins using transgenic animals. His innovative approach has the potential to advance medical research and therapeutic applications.

Latest Patents

Zhongtian Qi holds a patent for the "Production of human DNaseI in erythrocytes of transgenic non-human mammal using erythroid-specific promoter." This patent outlines a method for producing a non-erythroid protein in erythrocytes of a transgenic animal. The process involves synthesizing an erythroid-specific globin gene promoter and globin gene locus control region, cloning these elements along with a gene encoding a non-erythroid protein into a vector, and introducing the transgene into mammalian embryos. The resulting transgenic animal expresses the non-erythroid protein in progenitor cells of erythrocytes, allowing for the isolation of the protein from the animal's blood.

Career Highlights

Zhongtian Qi's career is marked by his dedication to advancing genetic engineering techniques. His innovative methods have garnered attention in the scientific community, showcasing his expertise in the field. With a patent count of 1 patent, he continues to contribute to the development of new biotechnological solutions.

Collaborations

Zhongtian Qi has collaborated with notable colleagues, including Hai Xing Chen and Hong Yang Wang. Their combined efforts in research and development have furthered advancements in genetic engineering and transgenic technology.

Conclusion

Zhongtian Qi's work exemplifies the intersection of innovation and biotechnology. His contributions to the production of non-erythroid proteins in transgenic animals highlight the potential for future advancements in medical research. His ongoing efforts in this field are likely to yield significant benefits for science and medicine.